Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis–associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind, Randomized, Placebo-controlled Trial is a research paper published in American Journal of Respiratory and Critical Care Medicine (2021). On theSindex it has a DataRank of 3.9. It has been cited 185 times, with 100 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.784
From this paper's citation signal
Citation Network Contribution
3.1
From 100 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 100 citers.
NHLBI NIH HHS
Grant: R01 HL082662
NIAID NIH HHS
Grant: UM1 AI110498
NHLBI NIH HHS
Grant: P01 HL014985
NHLBI NIH HHS
Grant: P01 HL108797
NHLBI NIH HHS
Grant: R01 HL141105
NIAID NIH HHS
Grant: U19 AI110491
NIAID NIH HHS
Grant: U19 AI046374
NIAID NIH HHS
Grant: U19 AI056363
NHLBI NIH HHS
Grant: R01 HL095686
NHLBI NIH HHS
Grant: R01 HL138473
NIAID NIH HHS
Grant: UM2 AI117870
NHLBI NIH HHS
Grant: K23 HL151892
NHLBI NIH HHS
Grant: U01 HL107393
FWCI
20.05
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Both T and B cells are indispensable for the development of a PBMC transfer-induced humanized mouse model for SSc
Additional file 1 of Both T and B cells are indispensable for the development of a PBMC transfer-induced humanized mouse model for SSc
Additional file 1 of The prognosis and management of reclassified systemic lupus erythematosus associated pulmonary arterial hypertension according to 2022 ESC/ERS guidelines
Additional file 1 of The prognosis and management of reclassified systemic lupus erythematosus associated pulmonary arterial hypertension according to 2022 ESC/ERS guidelines
Additional file 2 of The prognosis and management of reclassified systemic lupus erythematosus associated pulmonary arterial hypertension according to 2022 ESC/ERS guidelines
Additional file 2 of The prognosis and management of reclassified systemic lupus erythematosus associated pulmonary arterial hypertension according to 2022 ESC/ERS guidelines